|
NSMAF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.31000005182602E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30630000039211E-07 |
| Normal-vs-Stage2 |
1.244460E-03 |
| Normal-vs-Stage3 |
3.64330000002244E-06 |
| Normal-vs-Stage4 |
4.96490000001515E-07 |
| Stage1-vs-Stage2 |
9.291400E-01 |
| Stage1-vs-Stage3 |
7.033600E-01 |
| Stage1-vs-Stage4 |
7.047500E-02 |
| Stage2-vs-Stage3 |
8.705000E-01 |
| Stage2-vs-Stage4 |
2.180600E-01 |
| Stage3-vs-Stage4 |
1.669220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.08059996693089E-09 |
| Normal-vs-AfricanAmerican |
3.956000E-03 |
| Normal-vs-Asian |
8.458000E-02 |
| Caucasian-vs-AfricanAmerican |
4.685000E-01 |
| Caucasian-vs-Asian |
3.136000E-01 |
| AfricanAmerican-vs-Asian |
2.618200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.89389994984668E-09 |
| Normal-vs-Female |
1.39860000025749E-07 |
| Male-vs-Female |
7.414800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.521700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.06010000000545E-07 |
| Normal-vs-Age(61-80Yrs) |
7.04379998772708E-09 |
| Normal-vs-Age(81-100Yrs) |
5.406200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.126800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.178800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.873200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.163000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.421000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.000800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.100490E-03 |
| Normal-vs-Grade 2 |
9.21909999451742E-08 |
| Normal-vs-Grade 3 |
2.18499999982136E-07 |
| Normal-vs-Grade 4 |
3.93889999994457E-06 |
| Grade 1-vs-Grade 2 |
4.832400E-01 |
| Grade 1-vs-Grade 3 |
5.579600E-01 |
| Grade 1-vs-Grade 4 |
8.377800E-01 |
| Grade 2-vs-Grade 3 |
9.028000E-01 |
| Grade 2-vs-Grade 4 |
1.310960E-01 |
| Grade 3-vs-Grade 4 |
1.591160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.52710000000944E-06 |
| Normal-vs-ccB subtype |
4.8699999588564E-09 |
| ccA subtype-vs-ccB subtype |
3.348200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45520000494059E-08 |
| Normal-vs-N1 |
1.286230E-02 |
| N0-vs-N1 |
2.233400E-01 |
|
|
